These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14621363)

  • 1. What do I tell my patients about drinking water and the risk of bladder cancer?
    Moyad MA
    Urol Nurs; 2003 Oct; 23(5):371-7. PubMed ID: 14621363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
    Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
    Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrate in public water supplies and risk of bladder cancer.
    Ward MH; Cantor KP; Riley D; Merkle S; Lynch CF
    Epidemiology; 2003 Mar; 14(2):183-90. PubMed ID: 12606884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
    Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control study of male cancer patients exposed to arsenic-contaminated drinking water and tobacco smoke with relation to non-exposed cancer patients.
    Wadhwa SK; Kazi TG; Kolachi NF; Afridi HI; Khan S; Chandio AA; Shah AQ; Kandhro GA; Nasreen S
    Hum Exp Toxicol; 2011 Dec; 30(12):2013-22. PubMed ID: 21558145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
    Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer clusters in Florida: identifying populations at risk.
    Nieder AM; MacKinnon JA; Fleming LE; Kearney G; Hu JJ; Sherman RL; Huang Y; Lee DJ
    J Urol; 2009 Jul; 182(1):46-50; discussion 51. PubMed ID: 19450849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.
    Knobeloch LM; Zierold KM; Anderson HA
    J Health Popul Nutr; 2006 Jun; 24(2):206-13. PubMed ID: 17195561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
    Slotnick MJ; Meliker JR; Nriagu JO
    J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical reconstruction of wastewater and land use impacts to groundwater used for public drinking water: exposure assessment using chemical data and GIS.
    Swartz CH; Rudel RA; Kachajian JR; Brody JG
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):403-16. PubMed ID: 12973368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer: a selected review of the epidemiological literature.
    Pirastu R; Iavarone I; Comba P
    Ann Ist Super Sanita; 1996; 32(1):3-20. PubMed ID: 8967723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arsenic as an environmental problem].
    Jensen K
    Ugeskr Laeger; 2000 Dec; 162(49):6672-5. PubMed ID: 11188053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic and bladder cancer: observations and suggestions.
    Radosavljević V; Jakovljević B
    J Environ Health; 2008 Oct; 71(3):40-2. PubMed ID: 18990932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia].
    Luo FJ; Luo ZD; Ma L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):289-91. PubMed ID: 8706097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer and exposure to arsenic in rural Bangladesh.
    Mostafa MG; McDonald JC; Cherry NM
    Occup Environ Med; 2008 Nov; 65(11):765-8. PubMed ID: 18417558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.